Erlotinib added to bevacizumab as maintenance therapy and health-related quality of life in patients with metastatic colorectal cancer: Results of the GERCOR DREAM phase III trial.

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

PLoS ONE ◽

10.1371/journal.pone.0157067 ◽

2016 ◽

Vol 11 (6) ◽

pp. e0157067 ◽

Cited By ~ 8

Author(s):

Zeinab Hamidou ◽

Benoist Chibaudel ◽

Mohamed Hebbar ◽

Marine Hug de Larauze ◽

Thierry André ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Score ◽

Related Quality ◽

Health Related ◽

Dose Dense

Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3560 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3560-3560

Author(s):

Jane Chang ◽

Christopher Ngai ◽

Dawn Odom ◽

Christina Radder ◽

Christian Kappeler ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Phase Iii ◽

Health Related Quality ◽

Related Quality ◽

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Quality of Life (Qol) in Patients with Metastatic Colorectal Cancer (Mcrc) Receiving Maintenance Therapy After First-Line Inductive Treatment: a Qol Sub-Analysis of the Aio Krk 0207 Phase III Trial

Annals of Oncology ◽

10.1093/annonc/mdu333.25 ◽

2014 ◽

Vol 25 ◽

pp. iv177 ◽

Cited By ~ 1

Author(s):

J. Quidde ◽

D. Arnold ◽

S. Hegewisch-Becker ◽

U. Graeven ◽

C. Lerchenmüller ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Maintenance Therapy ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

Inductive Treatment

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.017 ◽

2012 ◽

Vol 48 (3) ◽

pp. 311-323 ◽

Cited By ~ 30

Author(s):

D. Cella ◽

A.S. Pickard ◽

M.S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

861 EFFECTS OF SUNITINIB VERSUS INTERFERON-ALFA IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A RANDOMIZED MULTINATIONAL PHASE III TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(07)60856-2 ◽

2007 ◽

Vol 6 (2) ◽

pp. 238 ◽

Cited By ~ 3

Author(s):

D. Cella ◽

J.Z. Li ◽

J.C. Cappelleri ◽

A. Bushmakin ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Renal Cell ◽

Interferon Alfa ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/nox168.834 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi206-vi206

Author(s):

Martin J B Taphoorn ◽

Linda Dirven ◽

Sophie Taillibert ◽

Jerôme Honnorat ◽

Thomas Chen ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

1108 POSTER Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib versus interferon (IFN)-alfa: results for European and US subsample analyses in a randomized, multinational phase III trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70627-4 ◽

2007 ◽

Vol 5 (4) ◽

pp. 144

Author(s):

D. Cella ◽

J.Z. Li ◽

A.G. Bushmakin ◽

J.C. Cappelleri ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

A nomogram to predict poor health-related quality of life in metastatic colorectal cancer patients

Annals of Oncology ◽

10.1093/annonc/mdz155.177 ◽

2019 ◽

Vol 30 ◽

pp. iv48

Author(s):

V. Formica ◽

A. Nardecchia ◽

C. Morelli ◽

J. Lucchetti ◽

G. Giuliano ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Cancer Patients ◽

Poor Health ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Colorectal Cancer Patients

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2019.05.003 ◽

2019 ◽

Vol 18 (3) ◽

pp. 183-191.e3 ◽

Cited By ~ 4

Author(s):

Rachel P. Riechelmann ◽

Vichien Srimuninnimit ◽

Roberto Bordonaro ◽

Petr Kavan ◽

Maria Di Bartolomeo ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Line Treatment ◽

Second Line ◽

Health Related Quality ◽

Safety And Health ◽

Related Quality ◽